The Greater Cannabis Company, Inc. (GCAN) is engaged in the development and commercialization of innovative cannabinoid therapeutics. Its primary focus is a licensed novel cannabinoid therapy from Shaare Zedek Scientific Ltd. targeting autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The company previously commercialized an oral transmucosal patch platform for cannabis delivery. It has completed preclinical studies and received Israel Ministry of Health approval to proceed with a Phase II Clinical Trial.
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001493152-26-014210 | EDGAR | 25K words |
| 2025-03-25 | 2024-12-31 | 0001641172-25-000512 | EDGAR | 21K words |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012098 | EDGAR | 21K words |
| 2023-04-13 | 2022-12-31 | 0001493152-23-012132 | EDGAR | — |
| 2022-04-12 | 2021-12-31 | 0001493152-22-009683 | EDGAR | — |
| 2021-03-26 | 2020-12-31 | 0001493152-21-006897 | EDGAR | — |
| 2020-04-14 | 2019-12-31 | 0001493152-20-006408 | EDGAR | — |
| 2019-04-15 | 2018-12-31 | 0001493152-19-005257 | EDGAR | — |
| 2018-04-17 | 2017-12-31 | 0001493152-18-005307 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001493152-26-038187 | EDGAR | 19K words |
| 2025-11-12 | 2025-09-30 | 0001493152-25-021810 | EDGAR | 18K words |
| 2025-08-08 | 2025-06-30 | 0001641172-25-022687 | EDGAR | 15K words |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009599 | EDGAR | 14K words |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044613 | EDGAR | 15K words |
| 2024-08-12 | 2024-06-30 | 0001493152-24-031106 | EDGAR | 14K words |
| 2024-05-14 | 2024-03-31 | 0001493152-24-019096 | EDGAR | 13K words |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040459 | EDGAR | 15K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-027962 | EDGAR | 14K words |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016758 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031748 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-023022 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-21 | 0001493152-26-043580 | EDGAR | 1K words |
| 2026-07-31 | 0001493152-26-035596 | EDGAR | 7K words |
| 2025-10-27 | 0001493152-25-019751 | EDGAR | 2K words |
| 2025-10-15 | 0001493152-25-018088 | EDGAR | 1K words |
| 2025-04-10 | 0001641172-25-003602 | EDGAR | 0K words |
| 2025-03-06 | 0001493152-25-009379 | EDGAR | 1K words |
| 2023-08-16 | 0001493152-23-029102 | EDGAR | 1K words |
| 2023-01-26 | 0001493152-23-002551 | EDGAR | — |
| 2022-06-21 | 0001493152-22-017277 | EDGAR | — |
| 2022-05-19 | 0001493152-22-014426 | EDGAR | — |
79 total filings indexed. 48 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001695473 |
| Ticker | GCAN |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | FL |
| Headquarters | North York, Ontario |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/GCAN (~200 tokens, structured JSON with cryptographic provenance)